BLEOMYCIN FOLLOWED BY CYCLOPHOSPHAMIDE, VINCRISTINE, METHOTREXATE, AND 5-FLUOROURACIL FOR NON-OAT CELL BRONCHOGENIC CARCINOMA

被引：0
|
作者：
LANZOTTI, VJ [1 ]
WARD, DN [1 ]
BOYLES, LE [1 ]
THOMAS, DR [1 ]
SMITH, TL [1 ]
SAMUELS, ML [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,SYST CANC CTR,HOUSTON,TX
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1975年 / 16卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：112 / 112
页数：1
相关论文
共 50 条
  • [21] 5-FLUOROURACIL, CYCLOPHOSPHAMIDE, AND VINCRISTINE FOR ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK
    TRIOZZI, PL
    BRANTLEY, A
    FISHER, S
    COLE, TB
    CROCKER, I
    HUANG, AT
    CANCER, 1987, 59 (05) : 887 - 890
  • [22] TREATMENT OF OAT CELL-CARCINOMA OF LUNG WITH CYCLOPHOSPHAMIDE, PROCARBAZINE, METHOTREXATE AND VINCRISTINE
    JOHNSON, PS
    FOLEY, JF
    LEMON, HM
    KESSINGER, MA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 418 - 418
  • [23] METASTATIC NON-OAT-CELL BRONCHOGENIC CARCINOMA - THERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, METHOTREXATE, AND PROCARBAZINE (CAMP)
    BITRAN, JD
    DESSER, RK
    DEMEESTER, T
    GOLOMB, HM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1978, 240 (25): : 2743 - 2746
  • [24] CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL VERSUS 5-FLUOROURACIL FOR CARCINOMA OF LARGE-INTESTINE IN ADVANCED PHASE
    SCANNI, A
    TOMIROTTI, M
    BIRAGHI, M
    ANNIBALI, E
    DELBIANCO, S
    MINERVA MEDICA, 1980, 71 (10) : 799 - 801
  • [25] COMBINATION CHEMOTHERAPY USING CYCLOPHOSPHAMIDE, VINCRISTINE, METHOTREXATE, 5-FLUOROURACIL, AND PREDNISONE IN SOLID TUMORS
    BEARDEN, JD
    COLTMAN, CA
    MOON, TE
    COSTANZI, JJ
    SAIKI, JH
    BALCERZAK, SP
    RIVKIN, SE
    MORRISON, FS
    LANE, M
    SPIGEL, SC
    CANCER, 1977, 39 (01) : 21 - 26
  • [26] HIGH-DOSE METHOTREXATE (HDMTX) WITH CITROVORUM FACTOR (CF) RESCUE IN INOPERABLE NON-OAT CELL BRONCHOGENIC CARCINOMA (NOBC)
    ETTINGER, DS
    STANLEY, KE
    NYSTROM, JS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 347 - 347
  • [27] Primary chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil in operable breast carcinoma
    Falo, C
    Moreno, A
    Benito, E
    Lloveras, B
    Varela, M
    Serra, J
    Prieto, L
    Azpeitia, D
    Escobedo, A
    CANCER, 2005, 103 (04) : 657 - 663
  • [28] COMBINED MODALITY THERAPY FOR STAGE-IIIMO NON-OAT CELL BRONCHOGENIC CARCINOMA
    BITRAN, JD
    DESSER, RK
    DEMEESTER, T
    SHAPIRO, CM
    BILLINGS, A
    RUBENSTEIN, L
    EVANS, R
    COLMAN, M
    RAO, Y
    GRIEM, M
    GOLOMB, HM
    CANCER TREATMENT REPORTS, 1978, 62 (03): : 327 - 332
  • [29] PLEURAL INVOLVEMENT IN IIIMO NON-OAT CELL BRONCHOGENIC-CARCINOMA - A NEED TO DIFFERENTIATE SUBTYPES
    ALBAIN, KS
    HOFFMAN, PC
    BITRAN, JD
    GOLOMB, HM
    DEMEESTER, TR
    LITTLE, AG
    RAGHAVAN, VT
    BLOUGH, RR
    SKOSEY, C
    CLINICAL RESEARCH, 1983, 31 (04): : A741 - A741
  • [30] Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma
    Livi, Lorenzo
    Saieva, Calogero
    Borghesi, Simona
    Paoletti, Lisa
    Meattini, Icro
    Rampini, Andrea
    Petrucci, Alessia
    Scoccianti, Silvia
    Paiar, Fabiola
    Cataliotti, Luigi
    Leonulli, Barbara Grilli
    Bianchi, Simonetta
    Biti, Gian Paolo
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (03): : 705 - 709
12345